SyntekaBio Inc (226330) — Cash Flow Quality Index

Latest as of June 2024: -2.40x

SyntekaBio Inc (226330) has a Cash Flow Quality Index of -2.40x as of June 2024. Operating cash flow of ₩-1.63 Billion is below net income of ₩677.08 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore 226330 asset base for the complete picture of this company's asset base.

Cash Flow Quality Index

-2.40x
Operating CF / Net Income

Operating Cash Flow

₩-1.63 Billion
KRW

Net Income

₩677.08 Million
KRW

Data as of

Jun 2024
Most recent filing

SyntekaBio Inc Cash Flow Quality Index (2018–2018)

Historical Cash Flow Quality Index for SyntekaBio Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 226330 tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for SyntekaBio Inc (2018–2018)

Year-by-year earnings quality comparison for SyntekaBio Inc. For live market cap and the full company financial profile, see market cap of SyntekaBio Inc.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2018 -0.63x ₩-2.37 Billion ₩3.75 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.